Skip to main content
SpringerLink
Log in

Mineral Levels in Thalassaemia Major Patients Using Different Iron Chelators

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The goal of the present study was to determine the levels of minerals in chronically transfused thalassaemic patients living in Antalya, Turkey and to determine mineral levels in groups using different iron chelators. Three iron chelators deferoxamine, deferiprone and deferasirox have been used to remove iron from patients’ tissues. There were contradictory results in the literature about minerals including selenium, zinc, copper, and magnesium in thalassaemia major patients. Blood samples from the 60 thalassaemia major patients (the deferoxamine group, n = 19; the deferiprone group, n = 20 and the deferasirox group, n = 21) and the controls (n = 20) were collected. Levels of selenium, zinc, copper, magnesium, and iron were measured, and all of them except iron showed no significant difference between the controls and the patients regardless of chelator type. Serum copper levels in the deferasirox group were lower than those in the control and deferoxamine groups, and serum magnesium levels in the deferasirox group were higher than those in the control, deferoxamine and deferiprone groups. Iron levels in the patient groups were higher than those in the control group, and iron levels showed a significant correlation with selenium and magnesium levels. Different values of minerals in thalassaemia major patients may be the result of different dietary intake, chelator type, or regional differences in where patients live. That is why minerals may be measured in thalassaemia major patients at intervals, and deficient minerals should be replaced. Being careful about levels of copper and magnesium in thalassaemia major patients using deferasirox seems to be beneficial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Fibach E, Rachmilewitz E (2008) The role of oxidative stress in hemolytic anemia. Curr Mol Med 8(7):609–619

    Article  CAS  PubMed  Google Scholar 

  2. Fung EB, Xu Y, Trachtenberg F, Odame I, Kwiatkowski JL, Neufeld EJ, Thompson AA, Boudreaux J, Quinn CT, Vichinsky EP (2012) Inadequate dietary intake in patients with thalassemia. J Acad Nutr Diet 112(7):980–990

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Baksi AJ, Pennell DJ (2014) Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major. Front Pharmacol 5:217. doi:10.3389/fphar.2014.00217

    Article  PubMed Central  PubMed  Google Scholar 

  4. Aaseth J, Skaug MA, Cao Y, Andersen O (2014) Chelation in metal intoxication-principles and paradigms. J Trace Elem Med Biol 31:260–266

    Article  PubMed  Google Scholar 

  5. Freeland-Graves JH, Sanjeevi N, Lee JJ (2014) Global perspectives on trace element requirements. J Trace Elem Med Biol 31:135–141. doi:10.1016/j.jtemb.2014.04.006

    Article  PubMed  Google Scholar 

  6. Sherief LM, Abd El-Salam SM, Kamal NM, El Safy O, Almalky MA, Azab SF, Morsy HM, Gharieb AF (2014) Nutritional biomarkers in children and adolescents with beta-thalassemia-major: an egyptian center experience. Biomed Res Int 2014:261761. doi:10.1155/2014/261761

    Article  PubMed Central  PubMed  Google Scholar 

  7. El Missiry M, Hamed Hussein M, Khalid S, Yaqub N, Khan S, Itrat F, Uderzo C, Faulkner L (2014) Assessment of serum zinc levels of patients with thalassemia compared to their siblings. Anemia 2014:125452. doi:10.1155/2014/125452

  8. Grubman A, White AR (2014) Copper as a key regulator of cell signalling pathways. Expert Rev Mol Med 16. doi: 10.1017/erm.2014.11

  9. De Franceschi L, Brugnara C, Beuzard Y (1997) Dietary magnesium supplementation ameliorates anemia in a mouse model of beta-thalassemia. Blood 90(3):1283–1290

    PubMed  Google Scholar 

  10. Maria C, Leonardo R, Pietro R, Mario V, Isabella V, Diana T (2010) Erythrocytes anion transport and oxidative change in beta-thalassaemias. Cell Biol Int 34(6):655–662. doi:10.1042/CBI20090472

    Article  CAS  PubMed  Google Scholar 

  11. Winter WE, Bazydlo LA, Harris NS (2014) The molecular biology of human iron metabolism. Lab Med 45(2):92–102

    Article  PubMed  Google Scholar 

  12. Roussou P, Tsagarakis NJ, Kountouras D, Livadas S, Diamanti-Kandarakis E (2013) Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress. Anemia 2013:617204. doi:10.1155/2013/617204

    Article  PubMed Central  PubMed  Google Scholar 

  13. Bartfay WJ, Bartfay E (2001) Selenium and glutathione peroxidase with beta-thalassemia major. Nurs Res 50(3):178–183

    Article  CAS  PubMed  Google Scholar 

  14. Mashhadi MA, Heidari Z, Sepehri Z, Bakhshipour AR, Karimkoshte A (2014) The selenium status in thalassemia patients in South East of Iran. Int J Hematol Oncol Stem Cell Re 8(4):1–4

    Google Scholar 

  15. Nasr MR, Ali S, Shaker M, Elgabry E (2002) Antioxidant micronutrients in children with thalassaemia in Egypt. East Mediterr Health J 8(4-5):490–495

    CAS  PubMed  Google Scholar 

  16. Al-Samarrai AH, Adaay MH, Al-Tikriti K, Al-Anzy MM (2008) Evaluation of some essential element levels in thalassemia major patients in Mosul district, Iraq. Saudi Med J 29(1):94–97

    PubMed  Google Scholar 

  17. Piga A, Gaglioti C, Fogliacco E, Tricta F (2003) Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica 88(5):489–496

    CAS  PubMed  Google Scholar 

  18. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood 107(9):3455–3462. doi:10.1182/blood-2005-08-3430

    Article  CAS  PubMed  Google Scholar 

  19. Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, Filosa A, Caruso V, Quarta A, Pitrolo L, Missere M, Midiri M, Rossi G, Positano V, Lombardi M, Maggio A (2011) Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging. Haematologica 96(1):41–47. doi:10.3324/haematol.2009.019042

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Haghpanah S, Zarei T, Zahedi Z, Karimi M (2013) Compliance and satisfaction with deferasirox (Exjade) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia. Hematology 19(4):187–191. doi:10.1179/1607845413Y.0000000121

    Article  PubMed  Google Scholar 

  21. Trachtenberg FL, Gerstenberger E, Xu Y, Mednick L, Sobota A, Ware H, Thompson AA, Neufeld EJ, Yamashita R (2014) Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Qual Life Res 23(8):2277–2288. doi:10.1007/s11136-014-0671-2

    Article  PubMed Central  PubMed  Google Scholar 

  22. Claster S, Wood JC, Noetzli L, Carson SM, Hofstra TC, Khanna R, Coates TD (2009) Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol 84(6):344–348. doi:10.1002/ajh.21416

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Ozturk Z, Genc GE, Kupesiz A, Kurtoglu E, Gumuslu S (2015) Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress. Free Radic Res 49(3):309–316. doi:10.3109/10715762.2015.1004327

    Article  CAS  PubMed  Google Scholar 

  24. Sultan S, Irfan SM, Kakar J, Zeeshan R (2015) Effect of iron chelator desferrioxamine on serum zinc levels in patients with beta thalassemia major. Malays J Pathol 37(1):35–38

    CAS  PubMed  Google Scholar 

  25. Mashhadi MA, Sepehri Z, Heidari Z, Shirzaee E, Kiani Z (2014) The prevalence of zinc deficiency in patients with thalassemia in South East of Iran, sistan and baluchistan province. Red Crescent Med J 16 (8):e6243. doi:10.5812/ircmj.6243

  26. Erdogan E, Canatan D, Ormeci AR, Vural H, Aylak F (2013) The effects of chelators on zinc levels in patients with thalassemia major. J Trace Elem Med Biol 27(2):109–111. doi:10.1016/j.jtemb.2012.10.002

    Article  CAS  PubMed  Google Scholar 

  27. Al-Samarrai AH, Adaay MH, Al-Tikriti KA, Al-Anzy MM (2008) Evaluation of some essential element levels in thalassemia major patients in Mosul district, Iraq. Saudi Med J 29(1):94–97

    PubMed  Google Scholar 

  28. Kajanachumpol S, Tatu T, Sasanakul W, Chuansumrit A, Hathirat P (1997) Zinc and copper status of thalassemic children. Southeast Asian J Trop Med Public Health 28(4):877–880

    CAS  PubMed  Google Scholar 

  29. Mashhadi MA (2013) Copper status in patients with thalassemia major in zahedan, Iran. Int J Hematol Oncol Stem Cell Res 7(3):21–24

    PubMed Central  PubMed  Google Scholar 

  30. Ghone RA, Kumbar KM, Suryakar AN, Katkam RV, Joshi NG (2008) Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Indian J Clin Biochem 23(4):337–340. doi:10.1007/s12291-008-0074-7

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Mahyar A, Ayazi P, Pahlevan AA, Mojabi H, Sehhat MR, Javadi A (2010) Zinc and copper status in children with beta-thalassemia major. Iran J Pediatr 20(3):297–302

    PubMed Central  PubMed  Google Scholar 

  32. de Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95(1):1–46. doi:10.1152/physrev.00012.2014

    Article  PubMed  Google Scholar 

  33. Naderi M, Sadeghi-Bojd S, Valeshabad AK, Jahantigh A, Alizadeh S, Dorgalaleh A, Tabibian S, Bamedi T (2013) A prospective study of tubular dysfunction in pediatric patients with beta thalassemia major receiving deferasirox. Pediatr Hematol Oncol 30(8):748–754. doi:10.3109/08880018.2013.823470

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank all members of the Pediatric Hematology Department, Akdeniz University Hospital. The authors would like to give special thanks to the patients, parents and healthy volunteers for their contribution to the study. This study was supported by a grant (Project no: 112S657) from TUBITAK (The Scientific and Technological Research Council of Turkey).

Author information

Authors and Affiliations

  1. Faculty of Medicine, Akdeniz University, Antalya, Turkey

    Gizem Esra Genc, Zeynep Ozturk, Saadet Gumuslu & Alphan Kupesiz

Authors
  1. Gizem Esra Genc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeynep Ozturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saadet Gumuslu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alphan Kupesiz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saadet Gumuslu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genc, G.E., Ozturk, Z., Gumuslu, S. et al. Mineral Levels in Thalassaemia Major Patients Using Different Iron Chelators. Biol Trace Elem Res 170, 9–16 (2016). https://doi.org/10.1007/s12011-015-0441-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-015-0441-1

Keywords

Search

Navigation